These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 28812208)

  • 21. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
    Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
    J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of genetic testing in unexplained sudden death.
    Miles CJ; Behr ER
    Transl Res; 2016 Feb; 168():59-73. PubMed ID: 26143861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-generation sequencing for the diagnosis of cardiac arrhythmia syndromes.
    Lubitz SA; Ellinor PT
    Heart Rhythm; 2015 May; 12(5):1062-70. PubMed ID: 25625719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric evaluation for inherited conditions: how do we investigate?
    Raju H; Behr ER
    Europace; 2011 Mar; 13(3):304-5. PubMed ID: 21131374
    [No Abstract]   [Full Text] [Related]  

  • 25. The genetics of cardiac disease associated with sudden cardiac death: a paper from the 2011 William Beaumont Hospital Symposium on molecular pathology.
    Perrin MJ; Gollob MH
    J Mol Diagn; 2012 Sep; 14(5):424-36. PubMed ID: 22749884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Legal and ethical implications of inherited cardiac disease in clinical practice within the UK.
    Hall AE; Burton H
    J Med Ethics; 2010 Dec; 36(12):762-6. PubMed ID: 21112937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Simple Practical Guide to Genomic Diagnostics in a Pediatric Setting.
    Taylor A; Alloub Z; Tayoun AA
    Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Testing in Inherited Arrhythmias: Approach, Limitations, and Challenges.
    Cheung CC; Tadros R; Davies B; Krahn AD
    Can J Cardiol; 2020 Apr; 36(4):584-587. PubMed ID: 32007350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. At the heart of genetic testing.
    Strauss S
    Nat Biotechnol; 2010 Oct; 28(10):1003-5. PubMed ID: 20944580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic Testing for Cardiomyopathies in Clinical Practice.
    Ingles J; Bagnall RD; Semsarian C
    Heart Fail Clin; 2018 Apr; 14(2):129-137. PubMed ID: 29525642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing in cardiovascular medicine: current landscape and future horizons.
    Sturm AC; Hershberger RE
    Curr Opin Cardiol; 2013 May; 28(3):317-25. PubMed ID: 23571470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosing kidney disease in the genetic era.
    Prakash S; Gharavi AG
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):380-7. PubMed ID: 26050126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repeat genetic testing with targeted capture sequencing in primary arrhythmia syndrome and cardiomyopathy.
    Robyns T; Kuiperi C; Breckpot J; Devriendt K; Souche E; Van Cleemput J; Willems R; Nuyens D; Matthijs G; Corveleyn A
    Eur J Hum Genet; 2017 Dec; 25(12):1313-1323. PubMed ID: 29255176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper.
    Gollob MH; Blier L; Brugada R; Champagne J; Chauhan V; Connors S; Gardner M; Green MS; Gow R; Hamilton R; Harris L; Healey JS; Hodgkinson K; Honeywell C; Kantoch M; Kirsh J; Krahn A; Mullen M; Parkash R; Redfearn D; Rutberg J; Sanatani S; Woo A
    Can J Cardiol; 2011; 27(2):232-45. PubMed ID: 21459272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and Management of
    Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
    South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparticipation athletic screening for genetic heart disease.
    Myerson M; Sanchez-Ross M; Sherrid MV
    Prog Cardiovasc Dis; 2012; 54(6):543-52. PubMed ID: 22687598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advising a cardiac disease gene positive yet phenotype negative or borderline abnormal athlete: is sporting disqualification really necessary?
    Richard P; Denjoy I; Fressart V; Wilson MG; Carré F; Charron P
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i59-68. PubMed ID: 23097481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Making prudent recommendations for return-to-play in adult athletes with cardiac conditions.
    Oliveira LP; Lawless CE
    Curr Sports Med Rep; 2011; 10(2):65-77. PubMed ID: 21623288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
    Girolami F; Bardi S; Berti L; Cecchi F; Servettini E; Tomberli B; Torricelli F; Olivotto I
    Recenti Prog Med; 2011 Dec; 102(12):486-93. PubMed ID: 22258194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of an Australian National Genetic Heart Disease Registry.
    Ingles J; McGaughran J; Vohra J; Weintraub RG; Davis A; Atherton J; Semsarian C
    Heart Lung Circ; 2008 Dec; 17(6):463-7. PubMed ID: 18722159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.